Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention

Heart, Artery and Coronary Diseases

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3-Vessel Coronary Artery Disease and Diabetes

J Am Heart Assoc

El-Andari R, Fialka N, Kang J, Hong Y, Kaul P, McAlister FA, Kent W, Nagendran J, Nagendran J

doi: 10.1161/JAHA.124.039663

Myocardial Infarction

Anatomical, physiological and inflammatory characterization of non-culprit vessels in patients undergoing primary PCI for ST-elevation myocardial infarction in the presence of multivessel disease: Rationale and design of the PICNIC study

Am Heart J

Mahmoudi M, Nicholas Z, Jabbour RJ, Shambrook J, Abbas A, Browne T, Hinton J, Antoniades C, Mamas M, Leipsic J, Rogers C, Koo BK, Al-Lamee R, Kontopantelis E, Curzen N

doi: 10.1016/j.ahj.2025.107298

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Left Ventricular Function on Outcomes in Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

Am Heart J

Pitaro N, Nicolas J, Sartori S, Shneyderman M, Feng Y, Vogel B, Oliva A, Smith KF, Sweeny J, Krishnana P, Gitto M, Kapur V, Muro FMD, Moreno P, Suleman J, Bay B, Hooda A, Sharma R, Krishnamoorthy PM, Kini A, Dangas G, Sharma S, Mehran R

doi: 10.1016/j.ahj.2025.06.017

Heart, Artery and Coronary Diseases

FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes

JAMA Cardiol

Takahashi K, Otsuki H, Zimmermann FM, Ding VY, Engstrøm T, Hørsted Thyregod HG, Beleslin B, Putnik S, Tapp L, Barker T, Redwood S, Young C, Bech GJ, Hoohenkerk GJF, De Bruyne B, Pijls NHJ, Fearon WF, FAME 3 Trial Investigators

doi: 10.1001/jamacardio.2025.0095

Heart, Artery and Coronary Diseases

Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial

Lancet

Fearon WF, Zimmermann FM, Ding VY, Takahashi K, Piroth Z, van Straten AHM, Szekely L, Davidavičius G, Kalinauskas G, Mansour S, Kharbanda R, Östlund-Papadogeorgos N, Aminian A, Oldroyd KG, Al-Attar N, Jagic N, Dambrink JE, Kala P, Angerås O, MacCarthy P, Wendler O, Casselman F, Witt N, Mavromatis K, Miner SES, Sarma J, Engstrøm T, Christiansen EH, Tonino PAL, Reardon MJ, Otsuki H, Kobayashi Y, Hlatky MA, Mahaffey KW, Desai M, Woo YJ, Yeung AC, Pijls NHJ, De Bruyne B

doi: 10.1016/S0140-6736(25)00505-7

Cardiac Arrest or Death

Complete versus culprit-lesion-only percutaneous coronary intervention after out-of-hospital cardiac arrest in patients with multivessel disease

Resuscitation

Raone L, Ferlini M, Bongiorno A, Bendotti S, Currao A, Primi R, Fava C, Laura D, Adamo M, Ghiraldin D, Marino M, Baldo A, Maffeo D, Kajana V, Affinito S, Baldi E, Luca L, Savastano S

doi: 10.1016/j.resuscitation.2024.110471

Atrial FibrillationMyocardial Infarction

New-Onset Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction: Risk of Recurrence and Its Clinical Impact During 10 Years of Follow-Up

J Am Heart Assoc

Demidova MM, Baturova MA, Erlinge D, Platonov PG

doi: 10.1161/JAHA.124.040478

Cardiac Arrest or Death

One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation: An Individual Patient Data Meta-Analysis

JAMA Cardiol

Spoormans EM, Thevathasan T, van Royen N, Zwinderman AH, Freund A, Thiele H, Ziesemer K, Desch S, Lemkes JS, COACT and TOMAHAWK Trials Investigators

doi: 10.1001/jamacardio.2025.1194

Heart, Artery and Coronary DiseasesMyocardial InfarctionTherapy and Intervention

Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Design of the AMUNDSEN Trial

Am Heart J

Montalescot G, Bolognese L, Bartus S, Cequier-Fillat A, Thiele H, Mach F, Jukema JW, Ferrari E, Souteyrand G, Bouleti C, Range G, Chioccioli M, Picchi A, Batias-Moreau L, Esposito G, Braik N, Redjimi N, Duband B, Guedeney P, Zeitouni M, Brochard K, Silvain J, Vicaut E, AMUNDSEN investigators of the ACTION Study Group

doi: 10.1016/j.ahj.2025.107295

Related content

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3-Vessel Coronary Artery Disease and Diabetes

Anatomical, physiological and inflammatory characterization of non-culprit vessels in patients undergoing primary PCI for ST-elevation myocardial infarction in the presence of multivessel disease: Rationale and design of the PICNIC study

Impact of Left Ventricular Function on Outcomes in Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes

Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial

Complete versus culprit-lesion-only percutaneous coronary intervention after out-of-hospital cardiac arrest in patients with multivessel disease

New-Onset Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction: Risk of Recurrence and Its Clinical Impact During 10 Years of Follow-Up

One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation: An Individual Patient Data Meta-Analysis

Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Design of the AMUNDSEN Trial